Stress-induced hyperthermia is reduced by rapid-acting anxiolytic drugs independent of injection stress in rats

Pharmacol Biochem Behav. 2009 Oct;93(4):413-8. doi: 10.1016/j.pbb.2009.05.017. Epub 2009 Jun 9.

Abstract

Background: Stress-induced hyperthermia (SIH) is the transient rise in body temperature after encountering a stressor. The SIH response can be blocked by administration of various anxiolytic drugs prior to inducing stress. However, a drug injection involves handling and injection stress and therefore induces a SIH response itself. In the standard SIH test, drugs are therefore injected 60 min before stress induction to allow injection-induced hyperthermia to decline. This makes it difficult to study putative anxiolytic compounds with a short half-life. The present study therefore aimed to compare the effects of standard (stressful) and stress-free anxiolytic drug administration on the subsequent SIH response with a 10-minute injection-stressor interval.

Methods: Anxiolytic drugs with short half-lives (midazolam, 8-OH-DPAT, nicotine) were injected subcutaneously in rats using either a stressful (manual injection) or stress-free injection (subcutaneous cannula) method 10 min before novel cage stress. Body temperature and locomotor activity were measured using telemetric transmitters.

Results: Stressful and stress-free drug administration resulted in comparable drug effects on the stress-induced hyperthermia and locomotor responses in rats.

Conclusion: The present study shows that both stressful and stress-free drug injection shortly before a stressor results in reproducible attenuation of the SIH response in rats. In rats, a short injection-stressor interval can therefore be applied using the SIH model, enabling the study of putative anxiolytic drugs with short half-lives.

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • Animals
  • Anti-Anxiety Agents / therapeutic use*
  • Body Temperature / drug effects
  • Drug Interactions
  • Fever / etiology*
  • Fever / prevention & control*
  • Injections, Intravenous / adverse effects*
  • Male
  • Midazolam / therapeutic use
  • Motor Activity / drug effects
  • Nicotine / pharmacology
  • Nicotinic Agonists / pharmacology
  • Rats
  • Rats, Wistar
  • Serotonin 5-HT1 Receptor Agonists
  • Stress, Psychological / complications*
  • Stress, Psychological / prevention & control*
  • Telemetry

Substances

  • Anti-Anxiety Agents
  • Nicotinic Agonists
  • Serotonin 5-HT1 Receptor Agonists
  • Nicotine
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • Midazolam